Clinical Trial Update: Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients

View source ↗

Summary

This completed NIAMS-funded study investigates factors predicting 2- to 5-year outcomes in a cohort of patients with early synovitis, including rheumatoid and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reactive Arthritis
• Rheumatoid Arthritis
• Synovitis

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Arthritis, Reactive, Arthritis, Rheumatoid | Status: COMPLETED